- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Women who skip mammo face higher risk of death
Older adult women who do not undergo regular screening mammography are more likely to die of breast cancer than women who are scanned, according to a long-term study of breast imaging in Massachusetts.
Older adult women who do not undergo regular screening mammography are more likely to die of breast cancer than women who are scanned, according to a long-term study of breast imaging in Massachusetts.
Dr. Blake Cady, professor emeritus of surgery at Harvard, and colleagues reviewed the cases of 6997 women who were diagnosed with invasive breast cancer between 1990 and 1999. All women also underwent follow-up through 2007. Cady confirmed 461 deaths, 116 for regularly screened women and 345 among women who were not regularly screened. Nearly two-thirds (60.9%) of deaths involved women who had never undergone screening while 5% occurred for those with at least one previous mammogram, but not within two years of diagnosis. The study was presented at the 2009 Breast Cancer Symposium in San Francisco.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
